Alpha Tau to Participate in Ladenburg’s Oncology Innovators & Investors Symposium

Provided By GlobeNewswire

Last update: Dec 6, 2024

JERUSALEM, Dec. 06, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT^®, today announced that CFO Raphi Levy will present at the Ladenburg Oncology Innovators & Investors Symposium.

Read more at globenewswire.com

ALPHA TAU MEDICAL LTD -27

NASDAQ:DRTSW (6/3/2025, 4:00:00 PM)

0.2298

+0.02 (+9.43%)

DRTSW Overview

DRTSW Technical Analysis Report

DRTSW Fundamental Analysis Report

ALPHA TAU MEDICAL LTD

NASDAQ:DRTS (6/4/2025, 8:20:34 PM)

2.94

-0.06 (-2%)